BPMC BLUEPRINT MEDICINES CORP Earnings Calls 8-K Filing 2024 - Webinar on Mast Cell-Targeted Therapies Blueprint Medicines Corp held a webinar on mast cell-targeted therapies and provided presentation materials.Get access to all SEC 8-K filings of the BLUEPRINT MEDICINES CORP